Changeflow GovPing Healthcare & Life Sciences HRS9531 Phase 3 Trial Beijing, Cardiovascular D...
Routine Notice Added Final

HRS9531 Phase 3 Trial Beijing, Cardiovascular Disease

Email

Summary

A Phase 3 clinical trial for HRS9531, an investigational treatment for cardiovascular disease, has been registered on ClinicalTrials.gov. The trial is being conducted in Beijing. No additional details regarding enrollment, endpoints, or study timeline are available in this registration entry.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.

What changed

A new clinical trial registration for HRS9531 Phase 3 has been added to ClinicalTrials.gov. The trial focuses on cardiovascular disease and is located in Beijing. This entry serves as a public record of the trial's existence and basic parameters.

Parties interested in cardiovascular disease treatments or clinical research should note this trial registration for potential partnership, competitive intelligence, or patient referral purposes. No compliance obligations or regulatory implications are associated with this notice.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Cardiovascular research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!